By Robert PreidtHealthDay Reporter WEDNESDAY, Aug. 11, 2021 (HealthDay News) — Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report. The new findings are important, they noted, because immunotherapy doesn’t typically work against microsatellite stable (MSS) colon cancer. These patients have few treatment options once … Read more
By Amy Norton HealthDay Reporter THURSDAY, Aug. 5, 2021 (HealthDay News) — In a first, researchers have used genetically tweaked immune system cells to send a woman’s severe lupus into remission. The treatment — called CAR T-cell therapy — is already approved in the United States for fighting certain cases of blood cancer. It involves … Read more
In the early 2000s, Caroline Williams started to notice tiny white flakes of skin on the shoulders of her clothes. “Dandruff,” she thought, and tried to treat it with over-the-counter remedies. But it got worse, and in 2004, she went to a doctor, who diagnosed psoriasis. For years afterward, doctors prescribed any number of creams, lotions, … Read more
In the early 2000s, Caroline Williams started to notice tiny white flakes of skin on the shoulders of her clothes. “Dandruff,” she thought, and tried to treat it with over-the-counter remedies. But it got worse, and in 2004, she went to a doctor, who diagnosed psoriasis. For years afterward, doctors prescribed any number of creams, … Read more
By Dennis Thompson HealthDay Reporter THURSDAY, May 20, 2021 (HealthDay News) — An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report. Atezolizumab reduced by 34% the risk of disease recurrence or death in a certain group of people with stage … Read more
By Robert PreidtHealthDay Reporter FRIDAY, April 2, 2021 (HealthDay News) — Combining stem cell transplants with cutting-edge immunotherapy prevents leukemia relapses in young people and improves their chances of survival, new research suggests. Acute lymphoblastic leukemia is the most common childhood cancer. This study included 50 patients (ages: 4 to 30) with acute lymphoblastic leukemia … Read more
SOURCES: cancer,gov: “Stopping Multiple Myeloma with New Treatments” cancer.gov: “Pomalidomide for Multiple Myeloma” Cancer.gov: “Drugs Approved for Multiple Myeloma” cancer.gov: “New Use for Lenalidomide in Multiple Myeloma” Hans C. Lee, MD, University of Texas MD Anderson Cancer Center. Blood: “Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.” FDA: … Read more
By Robert Preidt HealthDay Reporter THURSDAY, Oct. 1, 2020 (HealthDay News) — A newly approved drug for the leading form of the number one cancer killer, lung cancer, does improve patient survival, a new study confirms. The immunotherapy drug Tecentriq (atezolizumab) was approved earlier this year by the U.S. Food and Drug Administration … Read more
On an average cancer patient visits to hospitals have substantially declined by 64% after the outbreak. (Representational image: Reuters photo) The novel coronavirus disease or the COVID-19 pandemic initiated a national lockdown in India and rest of the world, bringing up massive challenges for the treatment of cancer patients. The pandemic has spread rapidly worldwide, … Read more